Targeted and non-targeted analyses of per-and polyfluoroalkyl substances in newborn dried blood spots and risk of childhood acute lymphoblastic leukemia

BACKGROUND: Per- and polyfluoroalkyl substances (PFAS) have carcinogenic potential but are understudied in relation to childhood cancers. OBJECTIVE: We examined associations between targeted and non-targeted PFAS measured in newborn dried blood spots (DBS) and the risk of childhood acute lymphoblastic leukemia (ALL) in Los Angeles County, California, accounting for maternal and child characteristics. METHODS: ALL cases (n = 125) diagnosed before age 18 years during 2000-2015 and controls (n = 219) were selected from a registry-based study using stratified sampling based on birth year and birth address within a PFAS-contaminated water district according to the USEPA Third Unregulated Contaminant Monitoring Rule. We calculated design-based odds ratios (OR) and 95% confidence intervals (CI) for the effect of PFAS exposures, independently and adjusting for other PFAS. We also conducted non-linear and stratified analyses. RESULTS: exposure (OR = 5.20, CI: 1.15, 23.56). Associations were generally stronger among non-Hispanic participants compared to Hispanic participants, but these analyses were limited by small sample sizes and should be considered exploratory. SIGNIFICANCE: There was some suggestion that high PFOA and PFOS exposures measured at birth, as well as certain PFAS detected by non-targeted approaches, were related to childhood ALL risk. IMPACT STATEMENT: This study of childhood ALL in Los Angeles County, California found increased risk among children with the highest PFOA and PFOS levels measured in neonatal dried blood spots. These risks were stronger among non-Hispanic children, and the greatest risk was observed for joint PFOA and PFOS exposure adjusting for other detected PFAS and maternal/child characteristics. We also observed possible associations with PFAS discovered by non-targeted analysis. Our results highlight the utility of dried blood spots as a matrix for assessing early life exposures as well as the value of hybrid targeted and non-targeted approaches to measure PFAS in health studies.